In the News

For press and media inquiries, e-mail press@journeyclinical.com

Featured press:

Psychedelics Today Podcast

Tune into the latest Psychedelics Today podcast episode with our CEO & Co-Founder Jonathan Sabbagh to learn more about our collaborative care model, and how you can incorporate psychedelic-assisted psychotherapy into your mental health practice in 2022.

Articles:

7 psychedelics startups that are set to take off, according to the most influential female VCs in the industry

Insider, March 24, 2022

Patients Prefer Their Existing Therapists; Journey Clinical Provides The Ketamine

The Dales Report, February 2, 2022

55 Tech Startups to Bet Your Career on in 2022

Insider, December 16, 2021

Unbundling Psychedelic Therapy

The Trip Report, October 1, 2021

Great News for Psychedelics Companies – Journey Clinical Raised $3M Funding For Mental Health Treatment

The Dales Report, September 30, 2021

Journey Clinical Raises $3M for its Service That Empowers Psychotherapists to Offer Psychedelic Therapy

AlleyWatch, September 30, 2021

How psychedelics changed my life (op-ed by Journey CEO Jonathan Sabbagh)

The Independent, September 28, 2021

Psychedelic Groundbreakers: Journey Clinical

Microdose, September 23, 2021

Turning Everyday Therapist Offices into Ketamine Clinics

Lucid News, September 20, 2021

Journey Clinical raises $3M to allow psychotherapists to offer psychedelic therapies

TechCrunch, September 17, 2021

VCs name the top 15 startups in the psychedelics industry

Insider, August 2, 2021

Millions to gain access to Psychedelic Psychotherapy in bid to fight pandemic induced depression and anxiety

Yahoo! Finance, June 17, 2021

Journey Clinical Launches Ketamine Prescription Service to Empower Independent Psychotherapists

Benzinga, June 11, 2021

Psychedelic healthcare fund Neo Kuma sees early success amid sector growth

Tech.eu, June 3, 2021

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice

Frontiers in Psychology, March 15, 2021